Selden.co.uk

SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
1.1. Product identifier
SELKIL HSE 4828
1.2. Relevant identified uses of the substance or mixture and uses advised against
1.3. Details of the supplier of the safety data sheet
Selden Research Limited
1.4. Emergency telephone number
01298 26226
SECTION 2: HAZARDS IDENTIFICATION
2.1. Classification of the substance or mixture
2.2. Label elements
R12 Extremely flammable., R40 Limited evidence of a carcinogenic effect., R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
S16 Keep away from sources of ignition - No smoking. S23 Do not breathe vapour/spray., P14 Contains PERMETHRIN. May produce an allergic reaction.
S2 Keep out of the reach of children.
2.3. Other hazards
PRESSURISED CONTAINER - increase in temperature to greater than 50C will cause internal pressure to rise potentially causing bursting/explosion.
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
3.1. Substances
3.2. Mixtures
Acute toxicity, category 4 - inhalation - H332 Acute toxicity, category 4 - Oral - H302 Skin sensitisation, categories 1, 1A, 1B - H317 Hazardous to the aquatic environment, acute, category 1 - H400 Hazardous to the aquatic environment, chronic, category 2 - H411 Hazardous to the aquatic environment, acute, category 1 - H400 Hazardous to the aquatic environment, chronic, category 2 - H411 STOT***, single exposure, category 3 - Narcotic effects - H336 Hazardous to the aquatic environment, acute, category 1 - H400 Hazardous to the aquatic environment, chronic, category 2 - H411 The Full Text for all R-Phrases and Hazard Statements are Displayed in Section 16.
SECTION 4: FIRST AID MEASURES
4.1. Description of first aid measures
Move the exposed person to fresh air at once., Keep the affected person warm and at rest. Get prompt medical attention.
Rinse mouth thoroughly., Drink plenty of water., Get medical attention.
Wash the skin immediately with soap and water., Get medical attention if any discomfort continues.
Spray in the eyes:, Promptly wash eyes with plenty of water while lifting the eye lids., Continue to rinse for at least 15 minutes., Get medical attention if any discomfort continues.
4.2. Most important symptoms and effects, both acute and delayed
May cause irritation to the respiratory system., Vapours may cause headache, fatigue, dizziness and nausea., Prolonged inhalation of high concentrations may damage respiratory system.
May cause burns in mucous membranes, throat, oesophagus and stomach., May cause stomach pain or Prolonged or repeated exposure may cause severe irritation., Acts as a defatting agent on skin. May cause Irritation of eyes and mucous membranes.
4.3. Indication of any immediate medical attention and special treatment needed
SECTION 5: FIREFIGHTING MEASURES
5.1. Extinguishing media
Use:, Powder., Dry chemicals, sand, dolomite etc., Water spray, fog or mist.
5.2. Special hazards arising from the substance or mixture
5.3. Advice for firefighters
Self contained breathing apparatus and full protective clothing must be worn in case of fire. Containers close to fire should be removed or cooled with water., Use water to keep fire exposed containers cool and SECTION 6: ACCIDENTAL RELEASE MEASURES
6.1. Personal precautions, protective equipment and emergency procedures
For personal protection, see section 8.
6.2. Environmental precautions
Any spillage needs to be contained and not allowed to enter water courses 6.3. Methods and material for containment and cleaning up
Wear necessary protective equipment., Extinguish all ignition sources. Avoid sparks, flames, heat and smoking. Ventilate., If leakage cannot be stopped, evacuate area.
6.4. Reference to other sections
For personal protection, see section 8. For waste disposal, see section 13.
SECTION 7: HANDLING AND STORAGE
7.1. Precautions for safe handling
Keep away from heat, sparks and open flame., Avoid spilling, skin and eye contact., Ventilate well, avoid breathing vapours. Use approved respirator if air contamination is above accepted level.
7.2. Conditions for safe storage, including any incompatibilities
Aerosol cans: Must not be exposed to direct sunlight or temperatures above 50°C.
7.3. Specific end use(s)
See product label for detailed usage and instructions.
SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1. Control parameters
8.2. Exposure controls
Provide adequate general and local exhaust ventilation.
SECTION 9: PHYSICAL AND CHEMICAL PROPERTIES
9.1. Information on basic physical and chemical properties
Information given relates to total aerosol container contents.
SECTION 10: STABILITY AND REACTIVITY
10.1. Reactivity
Stable under normal temperature conditions.
10.2. Chemical stability
Stable under normal temperature conditions.
10.3. Possibility of hazardous reactions
10.4. Conditions to avoid
Avoid heat, flames and other sources of ignition.
10.5. Incompatible materials
10.6. Hazardous decomposition products
Fire creates:, Toxic gases/vapours/fumes of:, Carbon monoxide (CO)., Carbon dioxide (CO2).
SECTION 11: TOXICOLOGICAL INFORMATION
11.1. Information on toxicological effects
No toxicological data is available for this mixture, however data can be provided for specific raw materials upon request.
May cause irritation to the respiratory system., Vapours may cause headache, fatigue, dizziness and nausea., Prolonged inhalation of high concentrations may damage respiratory system.
May cause burns in mucous membranes, throat, oesophagus and stomach., May cause stomach pain or vomiting.
Prolonged or repeated exposure may cause severe irritation., Acts as a defatting agent on skin. May cause cracking of skin, and eczema.
Irritation of eyes and mucous membranes.
SECTION 12: ECOLOGICAL INFORMATION
12.1. Toxicity
Harmful to aquatic organisms., May cause long term adverse effects in the aquatic environment.
12.2. Persistence and degradability
12.3. Bioaccumulative potential
The product does not contain any substances expected to be bioaccumulating.
12.4. Mobility in soil
The product contains volatile organic compounds (VOC) which will evaporate easily from all surfaces.
12.5. Results of PBT and vPvB assessment
This product does not contain any PBT or PvB substances 12.6. Other adverse effects
SECTION 13: DISPOSAL CONSIDERATIONS
13.1. Waste treatment methods
Empty containers must not be burned because of explosion hazard., Dispose of waste and residues in accordance with local authority requirements.
SECTION 14: TRANSPORT INFORMATION
14.1. UN number
14.2. UN proper shipping name
14.3. Transport hazard class(es)
14.4. Packing group
14.5. Environmental hazards
Environmentally Hazardous substance/Marine Pollutant Yes 14.6. Special precautions for user
14.7. Transport in bulk according to Annex II of MARPOL73/78 and the IBC Code
SECTION 15: REGULATORY INFORMATION
15.1. Safety, health and environmental regulations/legi

Source: http://www.selden.co.uk/sdsarchive/SELDEN_K002_K002.pdf

Project final summary

Project Final Summary NOT CONFIDENTIAL Information to be provided for project identification Title of the project DEVELOPMENT AND IMPLEMENTATION OF NEW ‘IN VIVO’ AND ‘IN VITRO’ SYSTEMS FOR THE CHARACTERIZATION OF ENDOCRINE DISRUPTORS Acronym of the project EDERA Total project cost (in euro) 879 000 € Contract number Duration (in months) EU contribution

Microsoft word - te lo io gli allarmismi inutili.doc

[email protected] (ordini)WWW.olisticnaturcenter.eu La strategia occulta delle lobbies del farmaco Marcello Pamio - 26 maggio 2007 Fonte: www.disinformazione.it Ogni tanto un farmaco usato da milioni di persone viene ritirato dal mercato perché provoca gravi danni all’organismo. Ogni tanto un farmaco viene ritirato perché provoca la morte stessa dei consumatori

© 2010-2018 Modern Medicine